Abstract
There are now over 20 review articles in pediatric psychopharmacology and they appear to be increasing in the 1970s (Sprague and Werry, 1971; Di Mascio et al., 1970; Renshaw, 1975; Freeman, 1970; Blackwell and Currah, 1973; Conners, 1972; Campbell, 1975b,c; Eisenberg and Conners, 1971; Greenberg and Lourie, 1972; Eveloff, 1970; Kornetsky, 1975). They function to simplify the process of keeping up with the ever-expanding number of papers in the field and to organize the numerous findings of separate studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adamson, W. C., Nellis, B. P., Runge, G., Cleland, C., and Killian, E., 1958, Use of tranquilizers for mentally deficient patients, AMA J. Dis. Child. 96:159–164.
Alderton, H. R., 1970, Imipramine in childhood enuresis: Further studies on the relationship of time of administration to effect, Can. Med. Assoc. J. 102:1179–1180.
Alexandris, A., and Lundell, F. W., 1968, Effect of thioridazine, amphetamine and placebo on the hyperkinetic syndrome and cognitive area in mentally deficient children, Can. Med. Assoc. J. 98:92–96.
Al-Kaisi, A. H., and McGuire, R. J., 1974, The effect of sulthiame on disturbed behaviour in mentally subnormal patients, Br. J. Psychiat. 124:45–49.
Aman, M. G., and Sprague, R. L., 1973, Effect of methylphenidate and dextroamphetamine on learning and retention, in Progress Report of Grant MH 18909 from 1970–1973 (R Sprague, Principal Investigator) (March, 1973).
Aman, M. G., and Sprague, R. L., 1974, The state-dependent effects of methylphenidate and detroamphetamine, J. Nerv. Ment. Dis. 158:268–279.
Andrews, G., and Harris, J., 1964, The syndrome of stuttering, Clin. Develop. Med. 17:160–167.
Anthony, E. J., 1959, An experimental approach to the psychopathology of childhood: Sleep, Br. J. Med. Psychol. 32:19–37.
Anton, A. H., and Greer, M., 1969, Dextroamphetamine, catecholamines, and behavior: The effect of dextroamphetamine in retarded children, Arch. Neurol. 21:248–252.
Arieff, A. J., and Mier, M., 1966, Anticonvulsant and psychotropic action of Tegretol, Neurology 16:107–110.
Ayllon, T., Layman, D., and Kandel, H. J., 1975, A behavioral-educational alternative to drug control of hyperactive children, J. Appl. Behav. 8:137–146.
Bair, H. V., and Herold, W., 1955, Efficacy of chlorpromazine in hyperactive mentally retarded children, AMA Arch. Neurol. Psychiat. 74:363–364.
Bakwin, H., 1973, The genetics of enuresis, Clin. Develop. Med. 48/49:73–77.
Bakwin, H., and Bakwin, R. M., 1972, Behavior Disorders in Children, 4th ed., pp. 546–553. W. B. Saunders, Philadelphia.
Balow, B., 1965, The long term effect of remedial reading instruction, Reading Teacher 18:581–586.
Bamberger, P., and Matthes, A., 1966, Effect of Valium on seizures and eeg in different forms of childhood epilepsy, Electroenceph. Clin. Neurophysiol. 20:103.
Ban, T. A., 1973, Haloperidol and the butyrophenones, Psychosomatics 14:286–297.
Barker, P., and Fraser, I. A., 1968, A controlled trial of haloperidol in children, Br. J. Psychiat. 114:855–857.
Barnes, M. R., and Fetterman, J. L., 1938, Mentality of dispensary epileptic patients, AMA Arch. Nenrol. Psychiat. 40:903–910.
Barnett, C., and Lampert, R., 1957, Effects of Metrazol on intellectual functioning in defectives, Psych. Rep. 3:551–554.
Beech, H. R., and Fransella, F., 1968, Research and Experiment in Stuttering, Pergamon Press, Oxford.
Benady, D. R., 1970, Cyproheptadine hydrochloride (Periactin) and anorexia nervosa: A case reporter. J. Psychiat 117:681–682.
Bender, L., 1953, Childhood schizophrenia, Psychiat. Quart. 27:663–681.
Bender, L., 1970, Children’s reactions to psychotomimetic drugs, in Psychotomimetic Drugs (D. H. Efron, ed.), pp. 265–271, Raven Press, New York.
Berger, M., Yule, W., and Rutter, M., 1975, Attainment and adjustment in two geographic areas II. The prevalence of specific reading retardation, Br. J. Psychiat. 126:510–519.
Bird, C. A., Griffin, B. P., Miklaszewska, J. M., and Galbraith, A. W., 1966, Tegretol (Carbamazepine): A controlled trial of a new anti-convulsant, Br. J. Psychiat. 112:737–742.
Blacklidge, V. Y., and Ekblad, R. L., 1971, The effectiveness of methylphenidate hydrochloride (Ritalin) on learning and behavior in public school educable mentally retarded children, Pediatrics 47:923–926.
Blackwell, B., and Currah, J., 1973, The psychopharmacology of nocturnal enuresis, Clin. Develop. Med. 48/49:231–257.
Blinder, B. J., Freeman, D. M., and Stunkard, A. J., 1970, Behavior therapy of anorexia nervosa: Effectiveness of activity as a reinforcer of weight gain, Am. J. Psychiat. 126:1093–1098.
Bonduelle, M., 1972, My study of Tegretol in the treatment of epilepsy, in Tegretol in Epilepsy (C. A. Winc, ed.), pp. 80–88, C. Nicholls and Company, Manchester.
Bradley, C., 1951, Behavior disturbances in epileptic children, JAMA 146:436–441.
Breger, E., 1961, Meprobamate in the management of enuresis, J. Pediat. 59:571–576.
Breger, E., 1962, Hydroxyzine hydrochloride and methylphenidate hydrochloride in the management of enuresis, J. Pediat. 61:443–447.
Brett, E. M., 1973, Epilepsy in childhood, Br. J. Hosp. Med. 9:177–186.
Broughton, R. J., 1968, Sleep disorders: Disorders of arousal? Science 159:1070–1078.
Brown, D., Winsberg, B. G., Bailer, I., and Press, M., 1973, Imipramine therapy and seizures: Three children treated for hyperactive behavior disorders, Am. J. Psychiat. 130:210–212.
Bruun, R., Shapiro, A. K., Sweet, R., Shapiro, E., Solomon, G., and Wayne, H., 1975, A follow-up study of Tourette’s syndrome in seventy-seven patients. Paper read at the Annual Meeting of the Amer. Psychiatric Assoc, Anaheim, California (May 9, 1975).
Buchanan, R. A., 1972, Ethosuximide: Toxicity, in Antiepileptic Drugs (D. M. Woodbury, J. K. Penry, and R. P. Schmidt, eds.), pp. 449–454, Raven Press, New York.
Burk, H. W., and Menolascino, F. J., 1968, Haloperidol in emotionally disturbed mentally retarded individuals, Am. J. Psychiat. 124:1589–1591.
Campbell, M., 1975a, Clinical trials of TRH (thyroid releasing hormones), Psychopharm. Bull. 11 (Jan.): 19–20.
Campbell, M., 1973, Biological interventions in psychoses of childhood, J. Aut. Child. Schiz. 3:347–372.
Campbell, M., 1975b, Psychopharmacology in childhood psychosis, Int. J. Mental Health 4:238–254.
Campbell, M., 1975c, Pharmacotherapy in early infantile autism, Biol. Psychiat. 10:399–423.
Campbell, M., Fish, B., Shapiro, T., and Floyd, A., 1970, Thiothixene in young disturbed children, Arch. Gen. Psychiat. 23:70–72.
Campbell, M., et al., 1971a, Imipramine in preschool autistic and schizophrenic children, J. Aut. Child. Schiz. 1:267–282.
Campbell, M., et al., 1971b, Study of Molindone in disturbed preschool children, Curr. Therap. Res. 13:28–33.
Campbell, M., Fish, B., David, R., Shapiro, T., Collins, P., and Koh, C., 1972a, Response to triiodothyronine and dextroamphetamine: A study of preschool schizophrenic children, J. Aut. Child. Schiz. 2:343–358.
Campbell, M., et al., 1972b, Acute responses of schizophrenic children to a sedative and a “stimulating” neuroleptic: A pharmacologic yardstick, Curr. Therap. Res. 14:759–766.
Campbell, M., Fish, B., Korein, J., Shapiro, T., Collins, P., and Koh, C., 1972c, Lithium and chlorpromazine: A controlled crossover study of hyperactive severely disturbed young children, J. Aut. Child. Schiz. 2:234–263.
Campbell, M., et al., 1973, Liothyronine treatment in psychotic and non-psychotic children under 6 years, Arch. Gen. Psychiat. 29:602–608.
Carter, C. H., 1959, Prochlorperazine in emotionally disturbed, mentally defective children, South Med. J. 52:174–178.
Chapel, J. L., Brown, N., and Jenkins, R. L., 1964, Tourette’s disease: Symptomatic relief with Haloperidol, Am. J. Psychiat. 121:608–610.
Christensen, D. E., 1975, Effects of combining methylphenidate and a classroom token system in modifying hyperactive behavior, Am. J. Ment. Defic. 80:266–276.
Christensen, D. E., and Sprague, R. L., 1973, Reduction of hyperactive behavior by conditioning procedures alone and combined with methylphenidate (Ritalin), Behav. Res. Therap. 11:331–334.
Cohen, M. W., 1975, Enuresis, Ped. Clin. N. Amer. 22:545–560.
Connell, P. H., Corbett, J. A., Horne, D. J., and Mathews, A. M., 1967, Drug treatment of adolescent ticquers: A double-blind trial of Diazepam and Haioperidol, Br. J. Psychiat. 113:375–381.
Conners, C. K., 1969, A teacher rating scale for use in drug studies with children, Am. J. Psychiat. 126:884–888.
Conners, C. K., 1972, Pharmacotherapy of psychopathology in children, in Psychopathological Disorders in Childhood (H. C. Quay and J. S. Werry, eds.), pp. 316–347, Wiley, New York.
Conners, C. K., 1973, Rating scales to use in drug studies with children, Psychopharm. Bull., Spec. Issue: Pharmacotherapy of Children, pp. 24-84.
Conners, C. K., 1974, Drug and cognition studies in disturbed children, Psychopharm. Bull. 10 (April):60–61.
Conners, C. K., 1975, Controlled trial of methylphenidate in preschool children with minimal brain dysfunction, Int. J. Mental Health 4:61–74.
Conners, C. K., and Rothschild, G., 1968, Drugs and learning in children, in Learning Disorders Vol. III (J. Hellmuth, ed.), pp. 191–224, Spec. Child Publ., Seattle, Washington.
Conners, C. K., Rothschild, G., Eisenberg, L., Schwartz, L. S., and Robinson, E., 1969, Dextroamphetamine sulfate in children with learning disorders: Effects on perception, learning and achievement, Arch. Gen. Psychiat. 21:182–190.
Conners, C. K., Kramer, R., Rothschild, G. H., Schwartz, L., and Stone, A., 1971, Treatment of young delinquent boys with diphenylhydantoin sodium and methylphenidate: A controlled comparison, Arch. Gen. Psychiat. 24:156–160.
Conners, C. K., Taylor, E., Meo, G., Kurtz, M. A., and Fournier, M., 1972, Magnesium pemoline and dextroamphetamine: A controlled study in children with minimal brain dysfunction, Psychopharmacologia 26:321–336.
Conners, C. K., Goyette, C., and Southwick, D., 1975, Food Additives and Hyperkinesis: Preliminary Report of a Double-Blind, Cross Over Experiment, unpublished manuscript.
Conrad, W. G., Dworkin, E. S., Shai, A., and Tobiessen, J. E., 1971, Effects of amphetamine therapy and prescriptive tutoring on the behavior and achievement of lower class hyperactive children, J. Learn. Disabil. 4:509–517.
Cookson, I. B., and Wells, P. G., 1973, Haloperidol in the treatment of stutterers, Br. J. Psychiat. 123:491.
Coolidge, J. C., Brodie, R. D., and Feeney, B., 1964, A ten-year follow-up study of sixty-six school-phobic children, Am. J. Orthopsychiat. 34:675–684.
Corbett, J. A., Mathews, A. M., Connell, P. H., and Shapiro, D. A., 1969, Tics and Gilles de la Tourette’s syndrome: A follow-up study and critical review, Br. J. Psychiat. 115:1229–1241.
Cordes, C. K., 1973, Chronic drug intoxication causing pseudoretardation in a young child, J. Am. Acad. Child. Psychiat. 12:215–222.
Craft, M., 1975a, Tranquilizers in mental deficiency: Hydroxyzine, J. Mental. Sci. 103:855–857.
Craft, M., 1957b, Tranquillizers in mental deficiency: Chlorpromazine, J. Mental Def. Res. 1:91–95.
Craft, M., 1958, Tranquillizers in mental deficiency: Meprobamate, J. Mental Def. Res. 2:17–20.
Craft, M., 1959, Mental disorder in the defective: The use of tranquillizers, Am. J. Mental Def. 64:63–71.
Creak, M., et al., 1961, Schizophrenic syndrome in childhood, Br. Med. J. 2:889–891.
Crisp, A. H., 1966, A treatment regime for anorexia nervosa, Br. J. Psychiat. 112:505–512.
Crisp, A. H., and Kalucy, R., 1973, The effect of leucotomy on intractable adolescent weight phobia (primary anorexia nervosa), Postgrad. Med. J. 49:883–893.
Cunningham, M. A., Pillai, V., and Rogers, W. J., 1968, Haloperidol in the treatment of children with severe behaviour disorders, Br. J. Psychiat. 114:845–854.
Dalby, M. A., 1971, Antiepileptic and psychotropic effect of carbamazepine (Tegretol) in the treatment of psychomotor epilepsy, Epilepsia 12:325–334.
Dally, P. J., and Sargant, W., 1966, Treatment and outcome of anorexia nervosa, Br. Med. J. 2:793–795.
Davidorf, F. H., 1973, Thioridazine pigmentary retinopathy, Arch. Opthalmol. 90:251–255.
DeJonge, G. A., 1973, Epidemiology in enuresis: A survey of the literature, Clin. Develop. Med. 48/49:39–46.
DeLeon, G., and Mandell, W., 1966, A comparison of conditioning and psychotherapy in the treatment of functional enuresis, J. Clin. Psych. 22:326–330.
Di Mascio, A., Soltys, J. J., and Shader, R. I., 1970, Psychotropic drug side effects in children, in Psychotropic Drug Side Effects (R. I. Shader, and A. Di Mascio, eds.), pp. 235–260, Williams and Wilkins, Baltimore.
Eisenberg, L., 1958, School phobia: Diagnosis, genesis, and clinical management, Ped. Clin. N. Am. 5:645–666.
Eisenberg, L., 1966a, The management of the hyperkinetic child, Develop. Med. Child Nenrol. 8:593–598.
Eisenberg, L., 1966b, Reading retardation: Psychiatric and sociologic aspects, Pediatrics 37:352–365.
Eisenberg, L., 1967, Psychotic disorders: Clinical features, in Comprehensive Textbook of Psychiatry (A. M. Freedman and H. I. Kaplan, eds.), pp. 1433–1438, Williams and Wilkins, Baltimore.
Eisenberg, L., and Conners, C. K., 1971, Psychopharmacology in childhood, in Behavioral Science in Pediatric Medicine (N. B. Talbot, J. Kagan, and L. Eisenberg, eds.), pp. 397–424, W. B. Saunders, Philadelphia.
Eisenberg, L., Gilbert, A., Cytryn, L., and Molling, P. A., 1961, The effectiveness of psychotherapy alone and in conjunction with perphenazine or placebo in the treatment of neurotic and hyperkinetic children, Am. J. Psychiat. 117:1088–1093.
Engelhardt, D. M., 1973, Outpatient pediatric psychopharmacology, Psychopharm. Bull., Spec. Issue: Pharmacotherapy of Children, pp. 11-13.
Engelhardt, D. M., Polizos, P., and Margolis, R., 1972, The drug treatment of childhood psychosis, in Drugs, Development and Cerebral Function (W. L. Smith, ed.), Charles Thomas, Springfield, Illinois.
Engelhardt, D. M., Polizos, P., Waizer, J., and Hoffman, S. P., 1973, A double-blind comparison of Fluphenazine and Haloperidol in outpatient schizophrenic children, J. Aut. Child. Schiz. 3:128–137.
Engelhardt, D. M., Polizos, P., and Waizer, J., 1975, CNS consequences of psychotropic drug withdrawal in autistic children: A follow-up report, Psychopharm. Bull. 11 (Jan.):6–7.
Epstein, L. C., Lasagna, L., Conners, C. K., and Rodriguez, A., 1968, Correlation of dextroamphetamine excretion and drug response in hyperkinetic children, J. Nerv. Mental Dis. 146:136–146.
Essman, W. B., 1971, Drug effects and learning and memory processes, Adv. Pharmacol. Chemother. 9:241–330.
Eveloff, H. H., 1970, Pediatrie psychopharmacology, in Principles of Psychopharmacology (W. G. Clark and J. del Guidice, eds.), pp. 683–694, Academic Press, New York.
Feingold, B., 1974, Why Your Child is Hyperactive, Random House, New York.
Finnerty, R. J., Soltys, J. J., and Cole, J. O., 1971, The use of D-amphetamine with hyperkinetic children, Psycopharmacologia 21:302–308.
Fish, B., 1960, Drug therapy in child psychiatry: Pharmacological aspects, Comp. Psychiat. 1:212–227.
Fish, B., 1971, The “one child one drug” myth of stimulants in hyperkinesis, Arch. Gen. Psychiat. 25:193–203.
Fish, B., 1973, Summary report of the children’s psychopharmacology unit at NYU Medical Center, Psychopharm. Bull., Spec. Issue, Pharmacotherapy of Children, pp. 13-18.
Fish, B., Shapiro, T., and Campbell, M., 1966, Long-term prognosis and the response of schizophrenic children to drug therapy: A controlled study of trifluperazine, Am. J. Psychiat. 123:32–39.
Fish, B., Campbell, M., Shapiro, T., and Floyd, A., 1969, Schizophrenic children treated with methysergide (Sansert), Dis. Nerv. Syst. 30:534–540.
Fisher, C., Kahn, E., Edwards, A., and Davis, D. M., 1973, A psychophysiological study of nightmares and night terrors: The suppression of stage 4 night terrors with Diazepam, Arch. Gen. Psychiat. 28:252–259.
Forrester, R. M., Stein, A., and Susser, M. W., 1964, A trial of conditioning therapy in nocturnal enuresis, Dev. Med. Child Nenrol. 6:158–166.
Forsythe, W. I., and Redmond, A., 1974, Enuresis and spontaneous cure rate: A study of 1129 enuretics, Arch. Dis. Child. 49:259–263.
Foster, J. C., and Anderson, J. E., 1936, Unpleasant dreams in childhood, Child Dev. 7:77–84.
Frederiks, J. A., 1970, Facial tics in children: The therapeutic effect of low-dosage Diazepam, Br. J. Clin. Pract. 24:17–20.
Freed, H., and Peifer, C. A., 1956, Treatment of hyperkinetic emotionally disturbed children with prolonged administration of Chlorpromazine, Am. J. Psychiat. 113:22–26.
Freedman, A. M., Effron, A. S., and Bender, L., 1955, Pharmacotherapy in children with psychiatric illness, J. Nerv. Mental Dis. 122:479–486.
Freedman, A. M., Deutsch, M., and Deutsch, C. P., 1960, Effects of hydroxyzine hydrochloride on the reaction time performance of schizophrenic children, Arch. Gen. Psychiat. 3:153–159.
Freeman, R. D., 1966, Drug effects on learning in children: A selective review of the past thirty years, J. Spec. Ed. 1:17–44.
Freeman, R. D., 1970, Psychopharmacology and the retarded child, in Psychiatric Approaches to Mental Retardation (F. Menolascino, ed.), pp. 294–368, Basic Books, New York.
Frommer, E. A., 1967, Treatment of childhood depression with antidepressant drugs, Br. Med. J. 1:729–732.
Gabourie, J., Becker, J. W., and Bateman, B., 1975, Oral dimethyl sulfoxide in mental retardation. Part I. Preliminary behavioral and psychometric data, Ann. N. Y. Acad. Sci. 243:449–459.
Gardner, W. I., 1971, Behavior Modification in Mental Retardation, Aldine-Atherton, Chicago.
Gestaut, H., Roger, J., and Lob, H., 1973, Medical treatment of epilepsy, in Anticonvulsant Drugs, Vol. 2 (J. Mercier, ed.), pp. 535–598, Pergamon Press, Oxford.
Giller, A., and Bernadou, M., 1975, Dimethyl sulfoxide therapy in nonmongoloid infantile oligophrenia, Ann. N. Y. Acad. Sci. 243:432–448.
Gittelman-Klein, R., 1975, Pharmacotherapy and management of pathological separation anxiety, Int. J. Ment. Health 4:255–271.
Gittelman-Klein, R., and Klein, D. F., 1971, Controlled Imipramine treatment of school phobia, Arch. Gen. Psychiat. 25:204–207.
Gittelman-Klein, R., and Klein, D., 1973, Methylphenidate effects in learning disability in children, Paper read at the 126th Annual Meeting of the Am. Psychiat. Assoc., Honolulu (May).
Gittelman-Klein, R., Klein, D. F., Flexibrod, J., Abikoff, H., Katz, S., Gloisten, A., Kates, W., and Saraf, K., 1975, Methylphenidate vs. behavior therapy in hyperkinetic children, Paper presented at the Annual Meeting of the Amer. Psychiat. Assoc., Anaheim, California (May).
Glaser, K., 1959, School phobia and related conditions, Pediatrics 23:371–383.
Glick, B. S., Schulman, D., and Turecki, S., 1971, Diazepam (Valium) treatment in childhood sleep disorders, Dis. Nerv. Syst. 32:565–566.
Goldfarb, W., 1970, Childhood psychosis, in Manual of Child Psychology, 3rd ed. (P. H. Mussen, ed.), pp. 765–803, Wiley, New York.
Goldman, R., 1966, The use of Mellaril as an adjunct in the treatment of stuttering, Excerpta Medica Int. Congr. Ser. No. 150 (Proc. IV World Congr. Psychiatry).
Graham, P., 1973, Depth of sleep and enuresis: A critical review, Clin. Dev. Med. 48/49:78–83.
Graham, B. D., Rosenblum, S., and Callahan, R. J., 1958, Placebo-controlled study of reserpine in maladjusted retarded children, AMA J. Dis. Child. 96:690–695.
Gram, L. F., and Rafaelsen, O. J., 1972, Lithium treatment of psychotic children and adolescents, Acta Psychiat. Scand. 48:253–260.
Grant, Q. R., 1962, Psychopharmacology in childhood emotional and mental disorders, Pediatrics 61:626–637.
Grant, R. H., 1974, Sulthiame and behaviour, Dev. Med. Child. Neurol. 16:821–823.
Green, J. R., Troupin, A. S., Halpern, L. M., Friel, P., and Kanarek, P., 1974, Sulthiame: Evaluation as an anticonvulsant, Epilepsia 15:329–349.
Greenbaum, G. C., 1970, An evaluation of niacinamide in the treatment of childhood schizophrenia, Am. J. Psychiat. 127:89–92.
Greenberg, L. M., and Lourie, R. S., 1972, Physiochemical treatment methods, in Manual of Child Psychopathology (B. B. Wolman, ed.), pp. 1010–1031, McGraw-Hill, New York.
Greenberg, L. M., Deem, M. A., and McMahon, S., 1972, Effects of dextroamphetamine, chlorpromazine, and hydroxyzine on behavior and performance in hyperactive children, Am. J. Psychiat. 129:532–539.
Greenhill, L. L., Rieder, R. O., Wender, P. H., Buchsbaum, M., and Zahn, T. P., 1973, Lithium carbonate in the treatment of hyperactive children, Arch. Gen. Psychiat. 28:636–640.
Griffiths, A. W., 1970, Drug trials, in Mental Subnormality: Modern Trends in Research (B. W. Richards, ed.), pp. 164–202, Pitman Medical and Scientific Publ. Co., London.
Gross, M. D., 1973, Imipramine in the treatment of minimal brain dysfunction in children, Psychosomatics 14:283–285.
Gross, M. D., and Wilson, W. C., 1974, Minimal Brain Dysfunction, Brunner/Mazel, New York.
Guey, J., Charles, C., Coquery, C., Roger, J., and Soulayrol, R., 1967, Study of psychological effects of ethosuximide (Zarontin) on 25 children suffering from petit mal epilepsy, Epilepsia 8:129–141.
Hackett, J. D., Hoffman, M., Macloed, A. S., and Surtees, R., 1958, A study of the effects of chlorpromazine as an aid to therapy for stuttering with a one year follow-up, Paper presented at the Amer. Speech and Hearing Assoc. Annual Convention in New York.
Harrington, M., 1960, Phenmetrazine in the treatment of nocturnal enuresis, Practitioner 185:343–346.
Hartlage, L. C., 1965, Effects of chlorpromazine on learning, Psych. Bull. 64:235–245.
Healy, C. E., 1974, Possible remedy for stuttering, Pediatrics 53:587–588.
Heaton-Ward, W. A., and Jancar, J., 1958, A controlled clinical trial of meprobamate in the management of difficult and destructive female mental defectives, J. Mental Sci. 104:454–456.
Helper, M. M., Wilcott, R. C., and Garfield, S. L., 1963, Effects of chlorpromazine on learning and related processes in emotionally disturbed children, J. Consult. Psych. 27:1–9.
Herjanic, B. M., and Penick, E. C., 1972, Adult outcome of disabled child readers, J. Spec. Ed. 6:397–410.
Hersov, L. A., 1960, Refusal to go to school, J. Child Psych. Psychiat. 1:137–145.
Hewett, F. M., Taylor, F. D., and Artuso, A. A., 1969, The Santa Monica project: Evaluation of an engineered classroom design with emotionally disturbed children, Except. Child, 35:523–529.
Holdsworth, L., and Whitmore, K., 1974, A study of children with epilepsy attending ordinary schools. 1. Their seizure patterns, progress, and behaviour in school, Develop. Med. Child. Neurol. 16:746–758.
Horwitz, F. D., and Paden, L. Y., 1973, The effectiveness of environmental intervention programs, in Review of Child Development Research, Vol. III (B. M. Caldwell and H. N. Ricciuti, eds.), pp. 331–402, Univ. of Chicago Press, Chicago.
Huestis, R., Arnold, L. E., and Smeltzer, D., 1975, Caffeine versus methylphenidate and d-amphetamine in minimal brain dysfunction: A double blind comparison, Am. J. Psychiat. 132:868–870.
Hunter, H., and Stephenson, G. M., 1963, Chlorpromazine and trifluperazine in the treatment of behavioural abnormalities in the severely subnormal child, Br. J. Psychiat. 109:411–417.
Hutt, C., Jackson, P. M., and Level, M., 1966, Behavioural parameters and drug effects: A study of a hyperkinetic epileptic child, Epilepsia 7:250–259.
Hutt, S. J., and Hutt, C., 1964, Hyperactivity in a group of epileptic (and some non-epileptic) brain-damaged children, Epilepsia 5:334–351.
Iivanainen, M., 1974, A study of the origins of mental retardation, Clin. Dev. Med. 51:39.
Ingram, T. T., 1956, A characteristic form of overactive behaviour in brain damaged children, J. Mental Sci. 102:550–558.
Irwin, S., 1974, The uses and relative hazard potential of psychoactive drugs, Bull. Menninger Clin. 38:14–48.
Ison, M. G., 1957, The effect of “Thorazine” on Wechsler scores, Am. J. Mental Def. 62:543–547.
Itil, T. M., and Myers, J. P., 1973, Epileptic and anti-epileptic properties of psychotropic drugs, in Anticonvulsant Drugs, Vol. 2 (J. Mercier, ed.), pp. 599–622, Pergamon Press, Oxford.
Itil, T. M., Rizzo, A. E., and Shapiro, D. M., 1967, Study of behavior and EEG correlation during treatment of disturbed children, Dis. Nerv. Syst. 28:731–736.
Jarvik, M. E., 1969, Effects of drugs on memory, in Drugs and the Brain (P. Black, ed.), pp. 135–146, Johns Hopkins Press, Baltimore.
Jencks, C., 1972, Inequality: A Reassessment of the Effect of Family and Schooling in America, Basic Books, New York.
Jenkins, R. L., and Stable, G., 1971, Special characteristics of retarded children rated as severely hyperactive, Child Psychiat. Hum. Dev. 2:26–31.
Johnson, A. M., 1957, School phobia workshop, 1955. 3. Discussion, Am. J. Orthopsychiat. 27:307–309.
Kahn, J. H., and Nursten, J. P., 1962, School refusal: A comprehensive view of school phobia and other failures of school attendance, Am. J. Orthopsychiat. 32:707–718.
Kay, D. W., and Leigh, D., 1954, The natural history, treatment and prognosis of anorexia nervosa, based on a study of 38 patients, J. Mental Sci. 100:411–431.
Kelly, D., Guirguis, W., Frommer, E., Mitchell-Heggs, N., and Sargant, W., 1970, Treatment of phobic states with antidepressants; a retrospective study of 246 patients, Br. J. Psychiat. 116:387–398.
Kelman, D. H., 1965, Gilles de la Tourette’s disease in children, a review of the literature, J. Child Psych. Psychiat. 6:219–226.
Kennedy, W. A., 1965, School phobia: Rapid treatment of fifty cases, J. Abn. Psych. 70:285–289.
Kenny, T. J., Badie, D., and Baldwin, R. W., 1968, The effectiveness of a new drug, Mesoridazine, and chlorpromazine with behavior problems in children, J. Nerv. Mental Dis. 147:316–321.
Kirman, B., 1975, Drug therapy in mental handicap, Br. J. Psychiat. 127:545–549.
Klein, D. F., 1964, Delineation of two drug-responsive anxiety syndromes, Psychopharmacologia 5:397–408.
Kneebone, G. M., 1968, The use of sulthiame (“Ospolot”) in the epileptic child with the hyperkinetic syndrome, Med. J. Aust. 2:1096–1097.
Knights, R. M., and Hinton, G. G., 1969, The effects of methylphenidate (Ritalin) on the motor skills and behavior of children with learning problems, J. Nerv. Mental Dis. 148:643–653.
Kornetsky, C., 1975, Minimal brain dysfunction and drugs, in Perceptual and Learning Disabilities in Children Vol. 2 (W. M. Cruickshank and D. P. Hallahan, eds.), pp. 447–481, Syracuse Univ. Press, Syracuse, New York.
Kraft, I. A., Marcus, I. M., Wilson, W., Swander, D. V., Rumage, N. S., and Schulhofer, E., 1959, Methodological problems in studying the effect of tranquilizers in children with specific reference to Meprobamate, South. Med. J. 52:179–185.
Krager, J. M., and Safer, D. J., 1974, Type and prevalence of medication used in the treatment of hyperactive children, New Eng. J. Med. 291:1118–1120.
Kugel, R. B., and Parsons, M. H., 1967, Children of Deprivation: Changing the Course of Familial Retardation: U. S. Dept. of HEW, Children’s Bureau, Washington, D. C.
Lapouse, R., and Monk, M. A., 1958, An epidemiologic study of behavior characteristics in children, Am. J. Public Health 48:1134–1144.
La Veck, G. D., and Buckley, P., 1961, The use of psychopharmacologic agents in retarded children with behavior disorders, J. Chron. Dis. 13:174–183.
Lazarus, A. A., Davison, G. C., and Polefka, D. A., 1965, Classical and operant factors in the treatment of a school phobia, J. Abn. Psych. 70:225–229.
Le Vann, L. J., 1962, Chlordiazopoxide, a tranquilizer with anticonvulsant properties, Canad. Med. Assoc. J. 86:123–125.
Le Vann, L. J., 1970, Clinical experience with Tarasan and Thioridazine in mentally retarded children: A comparative double blind study, Appl. Ther. 12 (May):30–33.
Le Vann, L. J., 1971, Clinical comparison of haloperidol with chlorpromazine in mentally retarded children, Am. J. Mental Def. 75:719–723.
Lindsley, D. B., and Henry, C. E., 1942, The effect of drugs on behavior and the electroencephalograms of children with behavior disorders, Psychosom. Med. 4:140–149.
Lipman, R. S., 1970, The use of psychopharmacological agents in residential facilities for the retarded, in Psychiatric Approaches to Mental Retardation (F. J. Menolascino, ed.), pp. 387–398, Basic Books, New York.
Lipsedge, M. S., Hajioff, J., Huggins, P., Napier, L., Pearce, J., Pike, D. J., and Rich, M., 1973, The management of severe agoraphobia: A comparison of Iproniazid and systematic desensitization, Psychopharmacologia 32:67–80.
Livingston, S., Kajdi, L., and Bridge, E. M., 1948, The use of benzedrine and dexedrine sulfate in the treatment of epilepsy, J. Pediat. 32:490–494.
Livingston, S., Pauli, L. L., and Berman, W., 1974, Carbamazepine (Tegretol) in epilepsy, Dis. Nerv. Syst. 35:103–107.
Louttit, R. T., 1965, Chemical facilitation of intelligence among the mentally retarded, Am. J. Mental Def. 69:495–501.
Lucas, A. R., 1964, Gilles de la Tourette’s disease in children: Treatment with phenothiazine drugs, Am. J. Psychiat. 121:606–608.
Lucas, A. R., and Pasley, F. C., 1969, Psychoactive drugs in the treatment of emotionally disturbed children: Haloperidol and Diazepam, Comp. Psychiat. 10:376–386.
Macfarlane, J. W., Allen, L., and Honzik, M. P., 1954, A Developmental Study of the Behavior Problems of Normal Children between Twenty-One Months and Fourteen Years, Univ. of California Press, Berkeley, California.
Mack, J., 1970, Nightmares and Human Conflict, Little, Brown, Boston.
MacLean, R. E., 1960, Imipramine hydrochloride (Tofranil) and enuresis, Am. J. Psychiat. 117:551.
Matti, N., Viukari, A., and Tammisto, P., 1969, Central effects of diphenylhydantoin (Dilantin) in epileptic oligophrenics during phenobarbital-primidone withdrawal, sodium bicarbonate, and ammonium chloride administration, Behav. Neuropsychiat. 1:13–16.
Maxmen, J. S., Silberfarb, P. M., and Ferrell, R. B., 1974, Anorexia nervosa: Practical initial management in a general hospital, JAMA 229:801–803.
May, P. R., 1968, Treatment of Schizophrenia: A Comparative Study of Five Treatment Methods, Science House, New York.
McAndrew, J. B., Case, Q., and Treffert, D. A., 1972, Effects of prolonged phenothiazine intake on psychotic and other hospitalized children, J. Aut. Child. Schiz. 2:75–91.
McConaghy, N., 1969, A controlled trial of imipramine, amphetamine, pad-and-bell conditioning and random awakening in the treatment of nocturnal enuresis, Med. J. Aust. 2:237–239.
McGaugh, J. L., 1969, Effects of analeptics on learning and memory in infrahumans, in Drugs and the Brain (P. Black, ed.), pp. 241–250, Johns Hopkins Univ. Press, Baltimore.
McKendry, J. B., and Stewart, D. A., 1974, Enuresis, Ped. Clin. N. Am. 21:1019–1028.
Meadow, R., 1974, Drugs for bed-wetting, Arch. Dis. Child. 49:257–258.
Mendelson, W., Johnson, N., and Stewart, M. A., 1971, Hyperactive children as teenagers: A follow-up study, J. Nerv. Mental Dis. 153:273–279.
Menolascino, F. J., 1965, Emotional disturbance and mental retardation, Am. J. Mental Def. 70:248–256.
Menolascino, F. J., 1969, Emotional disturbances in mentally retarded children, Am. J. Psychiat. 126:168–176.
Millichap, J. G., 1969, Management of hyperkinetic behavior in children with epilepsy, in Treatment of Epilepsy and Other Paroxysmal Disorders (J. G. Millichap, ed.), Hoebner, New York.
Millichap, J. G., and Fowler, G. W., 1967, Treatment of “minimal brain dysfunction” syndromes, Ped. Clin. N. Am. 14:767–777.
Millichap, J. G., Aymat, F., Sturgis, L. H., Larsen, K. W., and Egan, R. A., 1968, Hyperkinetic behavior and learning disorders III. Battery of neuropsychological tests in controlled test of methylphenidate, Am. J. Dis. Child. 116:235–244.
Milman, D. H., 1974, Haloperidol in stuttering, Pediatrics 54:660.
Mirsky, A. F., and Rosvold, H. E., 1960, The use of psychoactive drugs as a neuropsychological tool in studies of attention in man, in Drugs and Behavior (L. Uhr and J. G. Miller, eds.), pp. 375–392, Wiley, New York.
Mitchell, A. C., Hargis, C. H., McCarry, F., and Powers, C., 1959, Effects of prochlorperazine therapy on educability in disturbed mentally retarded adolescents, Am. J. Mental Def. 64:57–62.
Moffatt, W. R., Siddiqui, A. R., and MacKay, D. N., 1970, The use of sulthiame with disturbed mentally subnormal patients, Br. J. Psychiat. 117:673–678.
Molitch, M., and Eccles, A. K., 1937, The effect of benzedrine sulfate on the intelligence scores of children, Am. J. Psychiat. 94:588–590.
Molitch, M., and Sullivan, J. P., 1937, The effect of benzedrine sulfate on children taking the new Stanford Binet Achievement Test, Am. J. Orthopsychiat. 7:519–522.
Moore, B. C., Thuline, H. C., and Capes, L., 1968, Mongoloid and nonmongoloid retardates: A behavioral comparison, Am. J. Mental Def. 73:433–436.
Morgan, H., and Russell, G., 1975, Value of family background and clinical features as predictors of long-term outcome in anorexia nervosa: Four-year follow-up study of 41 patients, Psych. Med. 5:355–391.
Morgar, R. E., and Aldrich, R. W., 1969, The use of psychedelic agents with autistic schizophrenic children, Behav. Neuropsychiat. 1 (Nov.):44–52.
Mykelbust, H. R., and Boshes, B., 1969, Minimal Brain Damage in Children, U.S. Dept. of HEW, Washington, D.C.
Nellhaus, G., 1974, Management of seizure disorders in infancy, childhood and adolescence, in Drugs and the Developing Brain (A. Vernadakis and N. Wiener, eds.), pp. 503–520, Plenum Press, New York.
Nihira, K., 1973, Importance of environmental demands in the measurement of adaptive behavior, in Sociobehavioral Studies in Mental Retardation (G. Tarjan, R. K. Eyman and C. E. Meyers, eds.), pp. 101–116, Am. Assoc. Ment. Defic., Los Angeles, California.
O’Leary, S. G., and O’Leary, K. D., 1976, Behavior modification in the school, in Handbook of Behavior Modification and Behavior Therapy (H. Leitenberg, ed.), Prentice-Hall, Englewood Cliffs, New Jersey.
O’Leary, K. D., Pelham, W. E., Rosenbaum, A., and Price, G. H., 1976, Behavioral treatment of hyperkinetic children: An experimental evaluation of its usefulness, Clin. Pediat. 15:510–515.
Owen, J. D., 1971, The effects of chlorpromazine on performance of schizophrenic patients on two tests for brain damage and related measures, Dis. Abstr. Inter. 31:7B, 4343B (Jan.).
Page, J. G., Janicki, R. S., Bernstein, J. E., Curran, C. F., and Michelli, F. A., 1974, Pemoline (Cylert) in the treatment of childhood hyperkinesis, J. Learn. Disabil. 7:498–503.
Pallister, P. D., and Stevens, R. R., 1957, Effects of Serpasil in small dosage on behavior, intelligence, and physiology, Am. J. Mental Def. 62:267–274.
Parel, J. M., Black, N., Wharton, R. H., and Malitz, S., 1969, Inhibition of imipramine metabolism by methylphenidate, Fed. Proc. 28:418.
Pauig, P. M., Deluca, M. A., and Osterheld, R. G., 1961, Thioridazine hydrochloride in the treatment of behavior disorders in epileptics, Am. J. Psychiat. 117:832–833.
Paulson, G. W., and Buffaloe, W. J., 1964, Clinical note: Use of thioridazine hydrochloride in epilepsy, Dis. Nerv. Syst. 25:243.
Paulson, G. W., Rizvi, C. A., and Crane, G. E., 1975, Tardive dyskinesia as a possible sequel of long-term therapy with phenothiazines, Clin. Pediat. 14:953–955.
Pesikoff, R. B., 1973, Therapy for pavor nocturnus and somnambulism, Curr. Psychiat. Ther. 13:63–66.
Pesikoff, R. B., and Davis, P. C., 1971, Treatment of pavor nocturnus and somnambulism in children, Am. J. Psychiat. 128:778–781.
Petersen, K. E., Andersen, O. O., Hansen, T., 1974, Mode of action and relative value of imipramine and similar drugs in the treatment of nocturnal enuresis, Eur. J. Clin. Pharmacol. 7:187–194.
Petti, T. A., and Campbell, M., 1975, Imipramine and seizures, Am. J. Psychiat. 132:538–540.
Pilkington, T. L., 1961, Comparative effects of Librium and Taractan on behavior disorders of mentally retarded children, Dis. Nerv. Syst. 22:573–575.
Pilkington, T. L., 1962, A report on “Tofranil” in mental deficiency, Am. J. Mental Def. 66:729–732.
Pinkerton, P., 1975, Childhood Disorders—A Psychosomatic Approach, Columbia Univ. Press, New York.
Polizos, P., Engelhardt, D. M., Hoffman, S. P., and Waizer, J., 1973, Neurological consequences of psychotropic drug withdrawal in schizophrenic children, J. Aut. Child. Schiz. 3:247–253.
Pollack, M., 1970, Chlorpromazine and CNS changes in man, in Drugs and Cerebral Function (W. L. Smith, ed.), pp. 41–52, Charles Thomas, Springfield, Illinois.
Poussaint, A. F., Ditman, K. S., and Greenfield, R., 1966, Amitryptiline in childhood enuresis, Clin. Pharm. Ther. 7:21–25.
Pregelj, S., and Barkauskas, A., 1967, Thioridiazine in the treatment of mentally retarded children, Canad. Psychiat. Assoc. J. 12:213–215.
Quinn, P. O., and Rapoport, J. L., 1975, One-year follow-up of hyperactive boys treated with imipramine or methylphenidate, Am. J. Psychiat. 132:241–245.
Quinn, P. T., and Peachey, E. C., 1973, Haloperidol in the treatment of stutterers, Br. J. Psychiat. 123:247–248.
Rabiner, C. J., and Klein, D. F., 1969, Imipramine treatment of school phobia, Comp. Psychiat. 10:387–390.
Rapoport, J. L., Quinn, P. O., Bradbard, G., Riddle, D., and Brooks, E., 1974, Imipramine and methylphenidate treatments of hyperactive boys, Arch. Gen. Psychiat. 30:789–793.
Rawitt, K. C., 1959, The usefulness of effectiveness of Equanil in children, Am. J. Psychiat. 115:1120–1121.
Renshaw, D. C., 1975, Psychopharmacology in children, in Rational Psychopharmacology and the Right to Treatment (F. J. Ayd, ed.), pp. 131–150, Ayd Med. Communications Ltd., Baltimore.
Rettig, J. A., 1956, Chlorpromazine and mysoline in the control of convulsive epilepsy in mentally deficient patients, J. Nerv. Mental Dis. 124:607–611.
Rie, H. E., 1975, Hyperactivity in children, Am. J. Dis. Child. 129:783–789.
Ritvo, E. R., Ornitz, E. M., Gottlieb, F., Poussaint, A. F., Maron, B. J., Ditman, K. S., and Blinn, K. A., 1969, Arousal and nonarousal enuretic events, Am. J. Psychiat. 126:77–84.
Ritvo, E. R., Yuwiler, A., Geller, E., Kales, A., Rashkis, S., Schicor, A., Plotkin, S., Axelrod, R., and Howard, C., 1971, Effects of L-dopa in autism, J. Aut. Child. Schiz. 1:190–205.
Rodin, E. A., Rim, C. S., and Rennick, P. M., 1974, The effects of carbamazepine on patients with psychomotor epilepsy: Results of a double-blind study, Epilepsia 15:547–561.
Rodriguez, A., Rodriguez, M., and Eisenberg, L., 1959, The outcome of school phobia: A follow-up study based on 41 cases, Am. J. Psychiat. 116;540–544.
Rosenberger, P. B., Wheelden, J. A., and Kalotkin, M., 1976, The effect of haloperidol on stuttering, Am. J. Psychiat. 133:331–334.
Rudy, L. H., Himwich, H. E., and Rinaldi, F., 1958, A clinical evaluation of psychopharmacological agents in the management of disturbed mentally defective patients, Am. J. Mental Def. 62:855–860.
Russell, G. F., 1970, Anorexia nervosa: Its identity as an illness and its treatment, Mod. Trends Psych. Med. 2:131–164.
Rutter, M., 1965, The influence of organic and emotional factors on the origins, nature and outcome of childhood psychosis, Dev. Med. Child Nenrol. 7:518–528.
Rutter, M. L., 1971, Psychiatry, in Mental Retardation: An Annual Review, Vol. III (J. Wortis, ed.), pp. 186–221, Grune and Stratton, New York.
Rutter, M., Graham, P., and Yule, W., 1970a, A Neuropsychiatric Study in Childhood, Lippincott, Philadelphia.
Rutter, M. L., Tizard, J., and Whitmore, K., 1970b, Education, Health and Behaviour, Wiley, New York.
Rutter, M., Yule, W., and Graham, P., 1973, Enuresis and behaviour deviance: Some epidemiological considerations, Clin. Dev. Med. 48/49:137–147.
Sabot, L. M., Peck, R., and Raskin, J., 1969, The waiting room society: A study of families and children applying to a child psychiatric clinic, Arch. Gen. Psychiat. 21:25–32.
Safer, D. J., and Allen, R. P., 1975a, Side effects from long-term use of stimulants in children, Int. J. Mental Health 4:105–118.
Safer, D. J., and Allen, R. P., 1975b, Stimulant drug treatment of hyperactive adolescents, Dis. Nerv. Syst. 36:454–457.
Safer, D. J., and Allen, R. P., 1976, Hyperactive Children: Diagnosis and Management, University Park Press, Baltimore.
Safer, D. J., Allen, R. P., Calabria, R., Rodriguez, A., and Graham, R., 1972, Laboratory Correlates of Methylphenidate in Hyperactive Children, unpublished manuscript.
Safer, D. J., Allen, R. P., and Barr, E., 1975, Growth rebound after termination of stimulant drugs, J. Pediat. 86:113–116.
Saletu, B., Simeon, J., Saletu, M., Itil, T. M., and Da Silva, J., 1974, Behavioral and visual evoked potential investigations during trihexyphenidyl and thiothixene treatment in psychotic boys, Biol. Psychiat. 8:177–189.
Saletu, B., Saletu, M., Simeon, J., and Marasa, J., 1975a, Fluphenazine treatment in the psychotic child: Clinical-evoked potential correlations, Comp. Psychiat. 16:265–278.
Saletu, B., Saletu, M., Simeon, J., Viamontes, G., and Itil, T. M., 1975b, Comparative symptomatological and evoked potential studies with d-amphetamine, thioridazine, and placebo in hyperkinetic children, Biol. Psychiat. 10:253–275.
Salmon, M. A., 1973, The concept of day-time treatment for primary nocturnal enuresis, Clin. Dev. Med. 48/49:189–194.
Saraf, K. R., Klein, D. F., Gittelman-Klein, R., and Groff, S., 1974, Imipramine side effects in children, Psychopharmacologia 37:265–274.
Sargant, W., and Blackburn, J. M., 1936, The effect of benzedrine on intelligence scores, Lancet 2:1385–1387.
Schleifer, M., Weiss, G., Cohen, N., Elman, M., Cvejic, H., and Kruger, E., 1975, Hyperactivity in preschoolers and the effect of methylphenidate, Am. J. Orthopsychiat. 45:38–50.
Schnackenberg, R. C., 1973, Caffeine as a substitute for schedule II stimulants in hyperkinetic children, Am. J. Psychiat. 130:796–798.
Serrano, A. C., and Forbis, O. L., 1973, Haloperidol for psychiatric disorders in childhood, Dis. Nerv. Syst. 34:226–231.
Shaffer, D., Costello, A. J., and Hill, I. D., 1968, Control of enuresis with imipramine, Arch. Dis. Child. 43:665–671.
Shapiro, A. K., Shapiro, E., and Wayne, H., 1973, Treatment of Tourette’s syndrome with haloperidol, review of 34 cases, Arch. Gen. Psychiat. 28:92–97.
Sharpe, D. S., 1962, A controlled trial of trifluoperizine in the treatment of the mentally subnormal patient, J. Mental Sci. 108:220–224.
Sheehan, J. G., and Martyn, M. M., 1970, Stuttering and its disappearance, J. Speech Hearing Res. 13:279–289.
Shepherd, M., Oppenheim, B., and Mitchell, S., 1971, Childhood Behavior and Mental Health, Grune and Stratton, New York.
Silberberg, N. E., Iverson, I., and Goins, J., 1973, Which remedial reading method looks best? J. Learn. Disabil. 6:547–556.
Simeon, J., Utech, C., Simeon, S., and Itil, T. M., 1974a, Pediatric psychopharmacology outside the U.S.A., Dis. Nerv. Syst. 34 (July):37–47 (Section 2).
Simeon, J., Saletu, B., Saletu, M., Itil, T. M., and Da Silva, J., 1974b, Thiothixene in childhood psychoses, in Thiothixene and the Thioxanthenes (I. S. Forest, C. J. Carr, and E. Usdin, eds.), pp. 55–70, Raven Press, New York.
Sleator, E. K., Von Neumann, A., and Sprague, R. L., 1974, Hyperactive children: A continuous long-term placebo-controlled follow-up, JAMA 229:316–317.
Smith, W. L., Philippus, M. J., and Guard, H. L., 1968, Psychometric study of children with learning problems and 14-6 positive spike eeg patterns, treated with ethosuximide (Zarontin) and placebo, Arch. Dis. Child. 43:616–619.
Snyder, S., and Meyerhoff, J., 1973, How amphetamine acts in minimal brain dysfunction, Ann. N. Y. Acad. Sci. 205:310–320.
Somerfeld-Ziskind, E., and Ziskind, E., 1940, Effect of phenobarbital on the mentality of epileptic patients, AMA Arch. Neurol. Psychiat. 43:70–79.
Spencer, D. A., 1970, Ronyl (Pemoline) in overactive mentally subnormal children, Br. J. Psychiat. 117:239–240.
Sperling, M., 1971, Sleep disturbances in children, in Modern Perspectives in International Child Psychiatry (J. G. Howells, ed.), pp. 418–454, Brunner/Mazel, New York.
Sprague, R. L., and Werry, J. S., 1971, Methodology of psychopharmacological studies with the retarded, in International Review of Research in Mental Retardation, Vol. V (N. R. Ellis, ed.), pp. 147–219, Academic Press, New York.
Sprague, R. L., Barnes, K. R., and Werry, J. S., 1970, Methylphenidate and thioridazine: Learning, reaction time, activity and classroom behavior in disturbed children, Am. J. Orthopsychiat. 40:615–628.
Sprogis, G. R., Lezdins, V., White, S. D., Ming, C., Lanning, M., Drake, M. E., and Wycoff, G., 1957, Comparative study of thorazine and serpasil in the mental defective, Am. J. Ment. Def. 61:737–742.
Sroufe, L., 1975, Drug treatment of children with behavior problems, in Review of Child Development Research, Vol. IV (F. Horwitz, ed.), pp. 347–407, Univ. of Chicago Press, Chicago.
Stack, J. J., 1972, Chemotherapy in childhood depression, in Depressive States in Childhood and Adolescence (A. Annell, ed.), pp. 460–466, Halstead Press, New York.
Still, C., and Hans, C., 1973, Vesta variant of Tourette’s disease, South. Med. J. 66:1222–1225.
Stores, G., 1975, Behavioural effects of anti-epileptic drugs, Dev. Med. Child Neurol. 17:647–658.
Sunderland, J., Tait, H., and Eadie, M., 1974, The Epilepsies: Modern Diagnosis and Treatment, 2nd Ed., pp. 83–91, Churchill Livingston, Edinburgh.
Swift, W. J., Swift, E. W., and Arellano, M., 1975, Haloperidol as a treatment for adult stuttering, Comp. Psychiat. 16:61–67.
Tapia, F., 1969, Haldol in the treatment of children with tics and stutterers—and an incidental finding, Psychiat. Quart. 43:647–649.
Tarjan, G., Wright, S. W., Eyman, R. K., and Keeran, C. V., 1973, Natural history of mental retardation: Some aspects of epidemiology, Am. J. Mental Def. 77:369–379.
Tec, L., 1968, The treatment of enuresis with imipramine, Am. J. Psychiat. 125:266.
Tec, L., 1971, Anorexia nervosa—follow-up on a special method of treatment, Am. J. Psychiat. 127:1702.
Tec, L., 1974a, Nandrolone in anorexia nervosa, JAMA 228:1423.
Tec, L., 1974b, Imipramine for nightmares, JAMA 228:978.
Theander, S., 1970, Anorexia nervosa: A psychiatric investigation of 94 female patients, Acta Psychiat. Scand. Suppl. 214:5–194.
Timberlake, W. H., Belmont, E. H., and Ogonik, J., 1957, The effect of reserpine in 200 mentally retarded children, Am. J. Mental Def. 62:61–66.
Tizard, J., 1970, The role of social institutions in the causation, prevention and alleviation of mental retardation, in Socio-Cultural Aspects of Mental Retardation (H. C. Haywood, ed.), pp. 281–340, Appleton-Century-Crofts, New York.
Troupin, A. S., Green, J. R., and Halpern, L. M., 1975, Carbamazepine (Tegretol) as an anti convulsant: A controlled double-blind comparison with diphenylhydantoin (Dilantin), Acta Neurol. Scand. Suppl. 60:13–26.
Turner, R. K., 1973, Conditioning treatment of nocturnal enuresis: present status, Clin. Dev. Med. 48/49:195–210.
Tyrer, P., Candy, J., and Kelly, D., 1973, Phenelzine in phobic anxiety: A controlled trial, Psych. Med. 3:120–1204.
Ucer, E., and Kreger, K. C., 1969, A double-blind study comparing haloperidol with thioridazine in emotionally disturbed, mentally retarded children, Curr. Ther. Res. 11:278–283.
Van Riper, C. G., 1971, The Nature of Stuttering, Prentice-Hall, Englewood Cliffs, New Jersey.
Viukari, N., M., 1969, Diphenylhydantoin as an anticonvulsant: Evaluation of treatment in forty mentally subnormal epileptics, J. Mental Def. Res. 13:212–218.
Waizer, J., Polizos, P., Hoffman, S. P., Engelhardt, D. M., and Margolis, R. A., 1972, A single-blind evaluation of thiothixene with outpatient schizophrenic children, J. Aut. Child. Schiz. 2:378–386.
Waizer, J., Hoffman, S. P., Polizos, P., and Engelhardt, D. M., 1974, Outpatient treatment of hyperactive school children with imipramine, Am. J. Psychiat. 131:587–591.
Waldfogel, S., Coolidge, J. C., and Hahn, P. B., 1957, The development, meaning and management of school phobia, Am. J. Orthopsychiat. 27:754–780.
Waldfogel, S., Tessman, E., and Hahn, P. B., 1959, A program for early intervention in school phobia, Am. J. Orthopsychiat. 29:324–332.
Wallace, I. R., and Forsythe, W. I., 1969, The treatment of enuresis: A controlled clinical trial of propantheline, propantheline-and-phenobarbitone and a placebo, Br. J. Clin. Pract. 23:207–210.
Wapner, I., Thurston, D. L., and Holowach, J., 1962, Phenobarbital: Its effect on learning in epileptic children, JAMA 182:937.
Weinberg, W. A., and Harwell, J. L., 1965, Diazepam (Valium) in myoclonic seizures, Am. J. Dis. Child. 109:123–127.
Weiss, G., Werry, J., Minde, K., Douglas, V., and Sykes, D., 1968, Studies on the hyperactive child. V. The effects of dextroamphetamine and chlorpromazine on behaviour and intellectual functioning, J. Child Psych. Psychiat. 9:145–156.
Weiss, G., Minde, K., Werry, J. S., Douglas, V., and Nemeth, E., 1971a, Studies on the hyperactive child. VIII. Five-year follow-up, Arch. Gen. Psychiat. 24:409–414.
Weiss, G., Minde, K., Douglas, V., Werry, J., and Sykes, D., 1971b, Comparison of the effects of chlorpromazine, dextroamphetamine and methylphenidate on the behaviour and intellectual functioning of hyperactive children, Canad. Med. Assoc. J. 104:20–25.
Weiss, G., Kruger, E., Danielson, U., and Elman, M., 1975, Effect of long-term treatment of hyperactive children with methylphenidate, Canad. Med. Assoc. J. 112:159–165.
Wells, P. G., 1974, Haloperidol in the Treatment of Stutter, Med. J. Aust. 2:613.
Wells, P. G., and Malcolm, M. T., 1971, Controlled Trial of the Treatment of 36 Stutterers, Br. J. Psychiat. 119:603–604.
Werry, J. S., 1972a, Psychosomatic disorders, in Psychopathological Disorders of Childhood (H. C. Quay and J. S. Werry, eds.), pp. 122–172, Wiley, New York.
Werry, J. S., 1972b, Childhood Psychosis, in Psychopathological Disorders of Childhood (H. C. Quay and J. S. Werry, eds.), pp. 173–233, Wiley, New York.
Werry, J. S., and Aman, M. G., 1975, Methylphenidate and haloperidol in children: Effects on attention, memory, and activity, Arch. Gen. Psychiat. 32:790–795.
Werry, J. S., and Bull, D., 1975, Anorexia nervosa: A case study using behavior therapy, J. Am. Acad. Child Psychiat. 14:646–651.
Werry, J. S., and Cohrssen, J., 1965, Enuresis—An etiologic and therapeutic study, J. Pediat. 67:423–431.
Werry, J. S., and Wollersheim, J. P., 1967, Behavior therapy with children: A broad overview, J. Am. Acad. Child Psychiat. 6:346–370.
Werry, J. S., Weiss, G., Douglas, V., and Martin, J., 1966, Studies on the hyperactive child III. The effect of chlorpromazine upon behavior and learning ability, J. Am. Acad. Child Psychiat. 5:292–312.
Werry, J. S., Dowrick, P. W., Lampen, E. L., and Vamos, M. J., 1975, Imipramine in enuresis—Psychological and physiological effects, J. Child Psych. Psychiat. 16:289–299.
Whitehead, P. L., and Clark, L. D., 1970, Effect of lithium carbonate, placebo, and thioridazine on hyperactive children, Am. J. Psychiat. 127:824–825.
Winsberg, B. G., Press, M., Bialer, I., and Kupietz, S., 1974, Dextroamphetamine and methylphenidate in the treatment of hyperactive/aggressive children, Pediatrics 53:236–241.
Wolfensberger, W., and Menolascino, F., 1968, Basic considerations in evaluating ability of drugs to stimulate cognitive development in retardates Am. J. Mental Def. 73:414–423.
Wong, G. H., and Cock, R. J., 1971, Long-term effects of haloperidol on severely emotionally disturbed children, Aust. N. Z. J. Psychiat. 5:296–300.
Wyatt, G. L., 1969, Language Learning and Communication Disorders in Children, pp. 172–189, Free Press, New York.
Zimmerman, F. T., and Burgemeister, B. B., 1958, Action of methylphenidylacetate (Ritalin) and reserpine in behavior disorders in children and adults, Am. J. Psychiat. 115:323–328.
Zrull, J. P., Westman, J. C., Arthur, B., and Rice, D. L., 1964, A comparison of diazepam, D-amphetamine, and placebo in the treatment of the hyperkinetic syndrome in children, Am. J. Psychiat. 121:388–389.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Plenum Press, New York
About this chapter
Cite this chapter
Safer, D.J. (1978). Drug Treatment in Child Psychiatry. In: Iversen, L.L., Iversen, S.D., Snyder, S.H. (eds) Stimulants. Handbook of Psychopharmacology, vol 11. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0510-2_4
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0510-2_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-0512-6
Online ISBN: 978-1-4757-0510-2
eBook Packages: Springer Book Archive